This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LSX USA Congress

⏳ Early Bird Ends In....

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Life Science Partnering
Congress Sept 16-17, Forums Sept 15BCEC, Boston, USA
Tickets
Menu
Tickets
Key Sessions
Jessica Federer
Investing in Biotech Breakthroughs: A VC Outlook
Angelini Ventures
Ruchira Glaser
Biopharma 2025: Innovation, Collaboration, and Transformation in a New Era of Healthcare
Novartis
Lei Meng
Series A Secured, What's Next? Scaling Your Biotech
Bain Capital Life Sciences
Scott DeWire
The Art of the Acquisition: Redefining Pharma’s Future Through M&A
Boehringer Ingelheim
Jason Hafler
Funding Biotech Innovation: The CVC Perspective
Sanofi Ventures
Mike Patten
New Opportunities: How Asia’s Influence is Reshaping Biopharma in 2025
Harbour BioMed
keyboard_arrow_right

Day 1 – Tuesday, 16 Sept 2025 - ET (Eastern Time, GMT-05:00)

keyboard_arrow_leftSearch & Filter
search
Day 1 – Tuesday, 16 Sept 2025 - ET (Eastern Time, GMT-05:00)
search
Showing 1 of 1 Streams
3:50pm - 4:40pm
Biotech's Next Chapter: Innovating Smarter in a Changing Financial Landscape
  • Elizabeth Bailey - Co-Founder & Managing Partner, Foreground Capital
  • Kristian Werling - Global Head, Health and Life Sciences Practice Group, McDermott Will & Emery
  • Luba Greenwood - Managing Partner, Binney Street Capital Venture Fund, Dana-Farber Cancer Institute
  • Devin Rosenthal - Principal & Head of Due Diligence, NovaQuest Capital Management
  • Greg Fralish - CBO, GlycoEra
  • Bernard Cooney - Senior Partner, Flagship Pioneering
4:40pm - 5:30pm
The Art of the Acquisition: Redefining Pharma’s Future Through M&A
  • Scott DeWire - Corporate SVP, Head of Global BD&L, Boehringer Ingelheim
  • Nicole Daley - Partner, A&O Shearman
  • Konstantina Katcheves - SVP, Business Development, Alliance Management, & Acquisitions, Teva Pharmaceuticals
  • Stu Mackey - Global Head of Business Development, Daiichi-Sankyo
  • Issei Tsukamoto - SVP, Global Head Business Development, Astellas Pharma
Day 0 - Monday, 15th Sept 2025
NextDay 2 – Wednesday, 17 Sept 2025
Filter
Streams
Clear
Formats
Choose Day